Litigation Details for Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc. (N.D. Cal. 2024)
✉ Email this page to a colleague
Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc. (N.D. Cal. 2024)
| Docket | ⤷ Start Trial | Date Filed | 2024-06-13 |
| Court | District Court, N.D. California | Date Terminated | |
| Cause | 28:1337 Sherman-Clayton Act | Assigned To | Donna M. Ryu |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,166,242; 10,166,243; 10,195,214; 10,500,216; 8,921,348; 9,829,495; 9,943,526 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .
Details for Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc. (N.D. Cal. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-06-13 | 1 | Complaint | the ‘495 patent, U.S. Patent No. 9,943,526 (the ‘526 patent), U.S. Patent No. 10,166,242 (the ‘242 27 … patent), U.S. Patent No. 10,166,243 (the ‘243 patent), U.S. Patent No. 10,500,216 (the ‘216 patent),…348 patent) and U.S. patent number 9,829,495 9 (the ‘495 patent). Neither of these patents had…infringing two more patents: U.S. 13 patent number 10,842,800 (the ‘800 patent), and U.S. patent number 10,842,801… ‘348 patent at 1. 53 25 ‘348 patent col. 16 l. 25-35. The ‘348 patent also has six | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
